Primary Site >> Pancreatic Cancer

Gene >> ITCH

Journal: Nanomedicine. 2015 Feb;11(2):369-77.
Title: A nano-enabled cancer-specific ITCH RNAi chemotherapy booster for pancreatic cancer.
Author: de la Fuente, Maria|Jones, Marie-Christine|Santander-Ortega, Manuel J|Mirenska, Anja|Marimuthu, Preethi|Uchegbu, Ijeoma|Schatzlein, Andreas
PMID: 25267700
Journal: Oncotarget. 2016 Jan 12;7(2):1477-85.
Title: Negative correlation of ITCH E3 ubiquitin ligase and miRNA-106b dictates metastatic progression in pancreatic cancer.
Author: Luo, Zhu-Lin|Luo, Hui-Jun|Fang, Chen|Cheng, Long|Huang, Zhu|Dai, Ruiwu|Li, Kun|Tian, Fu-Zhou|Wang, Tao|Tang, Li-Jun
PMID: 26621835
Journal: Neoplasia. 2018 Feb;20(2):152-164.
Title: Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth.
Author: Pal, Anupama|Dziubinski, Michele|Di Magliano, Marina Pasca|Simeone, Diane M|Owens, Scott|Thomas, Dafydd|Peterson, Luke|Potu, Harish|Talpaz, Moshe|Donato, Nicholas J
PMID: 29248719
Journal: Mol Ther Nucleic Acids. 2018 Jun 1;11:142-158.
Title: miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-kappaB Signaling Pathways.
Author: Zhang, Xin|Ren, Dong|Wu, Xianqiu|Lin, Xi|Ye, Liping|Lin, Chuyong|Wu, Shu|Zhu, Jinrong|Peng, Xinsheng|Song, Libing
PMID: 29858050